Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research

Brook, 2009, Possible outcomes of comparative effectiveness research, JAMA, 302, 194, 10.1001/jama.2009.996 Tanenbaum, 2009, Comparative effectiveness research: evidence-based medicine meets health care reform in the USA, J Eval Clin Pract, 15, 976, 10.1111/j.1365-2753.2009.01322.x Cabana, 1999, Why don't physicians follow clinical practice guidelines? A framework for improvement, JAMA, 282, 1458, 10.1001/jama.282.15.1458 Greenfield, 2007, Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment, Am J Med, 120, 3, 10.1016/j.amjmed.2007.02.002 Hogben, 1953, The self-controlled and self-recorded clinical trial for low-grade morbidity, Br J Prev Soc Med, 7, 163 Hogben, 2011, The self-controlled and self-recorded clinical trial for low-grade morbidity, Int J Epidemiol, 40, 1438, 10.1093/ije/dyr026 Kent, 2010, Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal, Trials, 11, 85, 10.1186/1745-6215-11-85 Kravitz, 2004, Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages, Milbank Q, 82, 661, 10.1111/j.0887-378X.2004.00327.x Longford, 1999, Selection bias and treatment heterogeneity in clinical trials, Stat Med, 18, 1467, 10.1002/(SICI)1097-0258(19990630)18:12<1467::AID-SIM149>3.0.CO;2-H Tabery, 2011, Commentary: Hogben vs the Tyranny of averages (Reprinted), Int J Epidemiol, 40, 1454, 10.1093/ije/dyr027 2007 Kravitz, 2008, What Ever Happened to n-of-1 trials? Insiders' perspectives and a Look to the future, Milbank Q, 86, 533, 10.1111/j.1468-0009.2008.00533.x Lillie, 2011, The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?, Per Med, 8, 161, 10.2217/pme.11.7 Gabler, 2011, N-of-1 trials in the medical literature: a systematic review, Med Care, 49, 761, 10.1097/MLR.0b013e318215d90d Nikles, 2011, Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: the case of palliative care, J Clin Epidemiol, 64, 471, 10.1016/j.jclinepi.2010.05.009 Zucker, 1997, Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment, J Clin Epidemiol, 50, 401, 10.1016/S0895-4356(96)00429-5 Zucker, 2006, Lessons learned combining N-of-1 trials to assess fibromyalgia therapies, J Rheumatol, 33, 2069 Zucker, 2010, Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations, J Clin Epidemiol, 63, 1312, 10.1016/j.jclinepi.2010.04.020 Guyatt, 1986, Determining optimal therapy—randomized trials in individual patients, N Engl J Med, 314, 889, 10.1056/NEJM198604033141406 Guyatt, 1988, A clinician's guide for conducting randomized trials in individual patients, CMAJ, 139, 497 Guyatt, 1990, The n-of-1 randomized controlled trial—clinical usefulness. Our 3-year experience, Ann Intern Med, 112, 293, 10.7326/0003-4819-112-4-293 Larson, 1990, N-of-1 clinical-trials: a technique for improving medical therapeutics, West J Med, 152, 52 Larson, 1993, Randomized clinical-trials in single patients during a 2-year period, JAMA, 270, 2708, 10.1001/jama.1993.03510220064035 Curtiss, 2002, Single-patient trial (SPT) method, substitute for expert opinion?, J Manag Care Pharm, 8, 519 Federman, 2011, N-of-1 trials: not just for academics, J Gen Intern Med, 26, 115, 10.1007/s11606-010-1554-z Larson, 2010, N-of-1 trials: a new future?, J Gen Intern Med, 25, 891, 10.1007/s11606-010-1440-8 Rodnick, 2006, Australia: the N of 1 trial, an underappreciated research method, Fam Med, 38, 63 Sackett, 2011, Clinician-trialist rounds: 4. why not do an N-of-1 RCT?, Clin Trials, 8, 350, 10.1177/1740774511404718 Brookes, 2007, “Me's me and you's you”: Exploring patients' perspectives of single patient (n-of-1) trials in the UK, Trials, 8, 10, 10.1186/1745-6215-8-10 Kravitz, 2009, Marketing therapeutic precision: potential facilitators and barriers to adoption of n-of-1 trials, Contemp Clin Trials, 30, 436, 10.1016/j.cct.2009.04.001 Nikles, 2010, Stakeholders' views on the routine use of n-of-1 trials to improve clinical care and to make resource allocation decisions for drug use, Aust Health Rev, 34, 131, 10.1071/AH09654 Higgins, 1996, Borrowing strength from external trials in a meta-analysis, Stat Med, 15, 2733, 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0 Schmid, 2000, Bayesian hierarchical models, Methods Enzymol, 321, 305, 10.1016/S0076-6879(00)21200-7 Salanti, 2012, Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool, Res Synth Methods, 3, 80, 10.1002/jrsm.1037 Wei, 1978, Randomized play-winner rule in medical trials, J Am Stat Assoc, 73, 840, 10.1080/01621459.1978.10480109 Zelen, 1969, Play winner rule and controlled clinical trial, J Am Stat Assoc, 64, 131, 10.1080/01621459.1969.10500959 Whitehead, 1997 Berry, 2010